![](/img/cover-not-exists.png)
854 RESULTS OF A SAFETY, TOLERABILITY AND PHARMACOKINETIC PHASE I STUDY OF VCH-916, A NOVEL POLYMERASE INHIBITOR FOR HCV, FOLLOWING SINGLE ASCENDING DOSES IN HEALTHY VOLUNTEERS
L. Proulx, B. Bourgault, N. Chauret, R. Larouche, M. Tanguay, R. ThibertVolume:
48
Year:
2008
Language:
english
DOI:
10.1016/s0168-8278(08)60856-9
File:
PDF, 69 KB
english, 2008